Literature DB >> 12384773

Periodic catatonia: confirmation of linkage to chromosome 15 and further evidence for genetic heterogeneity.

Gerald Stöber1, Dominik Seelow, Franz Rüschendorf, Arif Ekici, Helmut Beckmann, André Reis.   

Abstract

We earlier reported significant evidence for linkage on chromosome 15q15 in periodic catatonia, a sub-phenotype of schizophrenic psychoses. The disorder is characterized by qualitative hyperkinetic and akinetic psychomotor disturbances through acute psychotic episodes and debilitating symptoms in the long term, with psychomotor weakness, grimacing facial movements and apathy. Here, we confirm mapping of a major gene locus on chromosome 15q15 in a second genome scan in a new set of four multiplex families. Non-parametric multipoint linkage analyses identified a broad region with a maximum peak of Z(all) =3.91 ( P=0.006) and Z(lr) =3.04 at D15S1234 ( P=0.001), satisfying conventional criteria for confirmed linkage. Parametric affected-only analyses under an autosomal dominant model gave a maximum HLOD score of 1.65 (D15S1234) with an estimated 47% of families being linked. Analysis of individual families showed that one large family showed linkage, whereas two others could be clearly excluded, confirming genetic heterogeneity. No other locus reached suggestive levels of significance. Haplotype analysis on chromosome 15 in this and previously linked families placed the susceptibility region to a 11-cM interval between marker D15S1042 and D15S659. Periodic catatonia is the first sub-phenotype of schizophrenic psychoses with confirmed linkage despite the existence of considerable genetic heterogeneity.

Entities:  

Mesh:

Year:  2002        PMID: 12384773     DOI: 10.1007/s00439-002-0805-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

Review 1.  Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series.

Authors:  Nancy J Butcher; Erik Boot; Anthony E Lang; Danielle Andrade; Jacob Vorstman; Donna McDonald-McGinn; Anne S Bassett
Journal:  Am J Med Genet A       Date:  2018-05-19       Impact factor: 2.802

Review 2.  Catatonia in patients with autism: prevalence and management.

Authors:  Luigi Mazzone; Valentina Postorino; Giovanni Valeri; Stefano Vicari
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

3.  Case 3: Regression in an adolescent with autism spectrum disorder.

Authors:  Sharon Smile
Journal:  Paediatr Child Health       Date:  2016 Jan-Feb       Impact factor: 2.253

4.  Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia.

Authors:  Sarah H Stephens; Alexis Franks; Ralph Berger; Milda Palionyte; Tasha E Fingerlin; Brandie Wagner; Judith Logel; Ann Olincy; Randal G Ross; Robert Freedman; Sherry Leonard
Journal:  Psychiatr Genet       Date:  2012-02       Impact factor: 2.458

5.  Systematic mutation analysis of KIAA0767 and KIAA1646 in chromosome 22q-linked periodic catatonia.

Authors:  Gerald Stöber; Bernd Kohlmann; Markus Iekiera; Claudia Rubie; Micha Gawlik; Kerstin Möller-Ehrlich; Thomas Meitinger; Thomas Bettecken
Journal:  BMC Psychiatry       Date:  2005-10-14       Impact factor: 3.630

6.  Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology.

Authors:  Annette E Rünker; Colm O'Tuathaigh; Mark Dunleavy; Derek W Morris; Graham E Little; Aiden P Corvin; Michael Gill; David C Henshall; John L Waddington; Kevin J Mitchell
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

7.  The catatonic dilemma expanded.

Authors:  Heath R Penland; Natalie Weder; Rajesh R Tampi
Journal:  Ann Gen Psychiatry       Date:  2006-09-07       Impact factor: 3.455

Review 8.  Wernicke-Kleist-Leonhard phenotypes 
of endogenous psychoses: a review of their validity
.

Authors:  Jack R Foucher; Micha Gawlik; Julian N Roth; Clément de Crespin de Billy; Ludovic C Jeanjean; Alexandre Obrecht; Olivier Mainberger; Julie M E Clauss; Julien Elowe; Sébastien Weibel; Benoit Schorr; Marcelo Cetkovich; Carlos Morra; Federico Rebok; Thomas A Ban; Barbara Bollmann; Mathilde M Roser; Markus S Hanke; Burkhard E Jabs; Ernst J Franzek; Fabrice Berna; Bruno Pfuhlmann
Journal:  Dialogues Clin Neurosci       Date:  2020-03       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.